The Wegovy pill is still dominating the GLP-1 pill market

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.

Jun 8, 2026

Add to Reading List

The Wegovy pill is still dominating the GLP-1 pill market

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.

I’m 60, retired with $3 million. My fiancée, 55, has $1 million but plans to work for the next 10 years. Are we compatible?

I’m 60, retired with $3 million. My fiancée, 55, has $1...

A new wave of weight-loss therapies aims to be better than today’s GLP-1s

A new wave of weight-loss therapies aims to be better t...

What nine different indicators say about market exuberance, according to Goldman Sachs

What nine different indicators say about market exubera...